2The antibiotic trimethoprim targets the bacterial dihydrofolate reductase enzyme and 3 subsequently affects the entire folate network. We present an expanded mathematical model of 4 trimethoprim's action on the Escherichia coli folate network that greatly improves upon Kwon et 5 al. (2008). The improvement upon the Kwon Model lends greater insight into the effects of 6 trimethoprim at higher resolution and accuracy. More importantly, the presented mathematical 7 model enables drug target discovery in a way the earlier model could not. Using the improved 8 mathematical model as a scaffold, we use parameter optimization to search for new drug targets 9 that replicate the effect of trimethoprim. We present the model and model-scaffold strategy as 10 an efficient route for drug target discovery.
1112 Introduction 13 Antibiotic resistance 14 Antibiotic resistance is a major health policy concern. New and resistant forms of 15 common infections such as tuberculosis necessitate urgent drug development efforts [1][2][3].16 Strategies such as discovering new bacterial communication networks and inhibiting these 17 networks are a popular avenue for drug discovery yet are very expensive in both time and 18 resources. Utilizing math models to gain a greater level of insight into the mechanisms of known 19 drugs may offer opportunities for drug development, using well-studied and richly described 20 pathways that already show weakness to chemical intervention to search for new potential 21 targets [4]. The presented work models the mechanism of a common antibiotic, trimethoprim, at 2 22 the biological information layer at which it functions, the metabolic network level. This is done 23 not only to study the mechanism of trimethoprim but to find alternatives to it by attempting to 24 replicate its effect on the folate network, which is known to be critical to cell function. The 25 presented mathematical model improves on previous work by providing a higher resolution 26 model of Trimethoprim's effect on E. coli. Without a highly detailed model of the bacterial folate 27 network and trimethoprim's effect on it, the presented strategy of drug target discovery would 28 not be possible. 29 The folate network and trimethoprim 30 The folate network is a traditional therapeutic target for both cancerous and bacterial 31 cells due to the integral role folates play in cell division [5, 6]. The folate network provides and 32 accepts one-carbon units for the biosynthesis of amino acids and metabolites such as S-adenosyl 33 methionine (SAM), the universal methyl group donor [7-9]. The antibiotic trimethoprim (TM) 34 inhibits the activity of bacterial dihydrofolate reductase (DHFR), an enzyme that converts 35 dihydrofolate (DHF) to tetrahydrofolate (THF, Fig 1). DHFR inhibition causes a spike in DHF. DHF 36 in turn inhibits folypolyglutamate gamma synthetase (FPGS), the enzyme tasked with adding 37 glutamates to THF and its derivatives [10, 11]. Because folate-catalyzed conversions of one-38 carbon units are sensitive to glutamation lev...